We enable decision-makers in clinical drug development to optimize outcomes and minimize risk in Phase 1b and Phase 2 trials by the use of advanced imaging techniques. We also provide expert support for product differentiation in life cycle management. We specialize in cardio-metabolic conditions and oncology/immuno-oncology.
www.antarosmedical.com
Investors 1
| Date | Name | Website |
| - | BioVenture... | azbioventu... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 16.04.2024 | The Incretin Impact: A New Era in Metabolic Disease and Obes... | www.antarosmedical.com In this free webinar, learn about incretins and their effects throughout the ... | prweb.com/... |